Asklepios BioPharmaceutical, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-29. The offering totals $199.7M, of which $199.7M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Fred Cohen | Director | AUSTIN, TX |
| Javier Garcia | Director | Cambridge, MA |
| William Hawkins | Director | The Woodlands, TX |
| Sheila Mikhail | Director | Durham, NC |
| Jon Salveson | Director | Plymouth, MN |
| Richard Samulski | Director | Durham, NC |
| John Schilling | Director | Fort Worth, TX |
| Katherine Wood | Director | Fort Worth, TX |
| Timothy Ferguson | Executive Officer | Sylacauga, AL |
| Sheila Mikhail | Executive Officer | Durham, NC |
| Richard Samulski | Executive Officer | Durham, NC |